KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical Manufacturing
Products
KBI Biopharma, Inc. JSR Life Sciences companies, announced the launch of KBI PUREplatform™, a premium microbial cell line development (CLD) platform.
The platform addresses known industry challenges such as low titers, poor product quality, and capacity constraints, empowering customers to significantly improve processes to bring products to market cheaper and easier.
For details, please see the announcement from JSR Life Sciences LLC on URL.